FDA to withdraw certain drug-related guidances with end of PHE
By
Alicia Lasek
Mar 14, 2023
The Food and Drug Administration has issued a notice detailing which COVID-19-related guidances will expire when the public health emergency ends as scheduled on May 11, and which guidances will remain...
Time from infection to COVID symptoms shortens with each new variant, study finds
By
Alicia Lasek
Aug 24, 2022
The average incubation period of SARS-CoV-2 has gradually shortened, from 5 days to 3.4. Determining incubation periods can help to pinpoint effective patient isolation periods, investigators say.
Clinical briefs for Wednesday, Dec. 1
By
Alicia Lasek
Dec 01, 2021
Regeneron’s COVID-19 antibody drug may be less effective against omicron, drugmaker says … Pandemic taking toll on healthcare workers’ sleep patterns … Ambulance staffing shortage frustrating nursing...
Feds halt an Eli Lilly antibody therapy in 3 states due to variant fears, while boosting the treatment...
By
Alicia Lasek
Mar 19, 2021
A COVID-19 variant circulating widely in California, Arizona and Nevada has rendered bamlanivimab alone ineffective, an FDA official reports. But Lilly says an approved alternative treatment “maintains...
Amyloid-busting drug for early Alzheimer’s fails to stop cognitive decline, long-term study concludes
By
Alicia Lasek (f3)
Jun 21, 2022
The failure of a more-than-decade-long trial in patients with early-onset Alzheimer’s deals yet another blow to a key treatment theory, observers say.
ADHD linked to Alzheimer’s disease across generations, scientists say
By
Alicia Lasek
Sep 14, 2021
Parents of children diagnosed with attention deficit hyperactivity disorder are more likely to receive a diagnosis of Alzheimer’s than their peers whose children do not have the condition, investigators...
Alzheimer’s origin story is about metabolism and lifestyle, scientists contend
By
Alicia Lasek
Apr 02, 2021
Alzheimer’s Disease is increasingly being referred to as insulin resistance of the brain, or Type 3 diabetes, a research team says.
Porter: Election controversy or not, all efforts now go to lame duck stimulus package
By
James M. Berklan
Nov 09, 2020
Long-term care providers and their lobbyists are “completely and totally” focused on dealing with the coronavirus pandemic, regardless of the presidential election results, a top association leader...
Vitamin D3 does not reduce fracture risk in healthy older adults: study
By
Alicia Lasek (f3)
Jul 29, 2022
Results from a large clinical trial do not support the use of vitamin D supplements to reduce fractures in generally healthy men and women, investigators say.
Feds gauging threat to vaccine, test and treatment efficacy in face of omicron variant
By
Alicia Lasek
Dec 01, 2021
The United States is prepared to address any potential threat to the effectiveness of COVID-19 vaccines, tests and treatments posed by the new variant, according to the White House and federal health officials.